Jim Simons Connect Biopharma Holdings LTD Put Options Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CNTB
# of Institutions
17Shares Held
3.28MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$2.01 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$490,2720.04% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$154,4320.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$99,7350.0% of portfolio
-
Royal Bank Of Canada Toronto, A680.4KShares$77,1840.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $52.8M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...